共 10 条
- [1] Intensity-modulated radiotherapy and involved-node concept in patients with Hodgkin lymphoma: Experience of the Gustave-Roussy Institute CANCER RADIOTHERAPIE, 2011, 15 (08): : 709 - 715
- [2] Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 268 - 276
- [3] Dosimetric and Clinical Outcomes of Involved-Field Intensity-Modulated Radiotherapy After Chemotherapy for Early-Stage Hodgkin's Lymphoma With Mediastinal Involvement INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (01): : 210 - 216
- [4] PREDICTED RISK OF RADIATION-INDUCED CANCERS AFTER INVOLVED FIELD AND INVOLVED NODE RADIOTHERAPY WITH OR WITHOUT INTENSITY MODULATION FOR EARLY-STAGE HODGKIN LYMPHOMA IN FEMALE PATIENTS INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 490 - 497
- [5] MILD TOXICITY AND FAVORABLE PROGNOSIS OF HIGH-DOSE AND EXTENDED INVOLVED-FIELD INTENSITY-MODULATED RADIOTHERAPY FOR PATIENTS WITH EARLY-STAGE NASAL NK/T-CELL LYMPHOMA INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1115 - 1121